Viatris Loses US Challenge To Januvia And Janumet Patents
US Firm May Appeal; Has Appealed Negative USPTO Decision
Viatris’ attempts to deliver US generic versions of sitagliptin and sitagliptin/metformin ahead of patent expiry has failed for now, with an unfavorable judgment from a district court in West Virginia. More than 20 ANDA sponsors have opted to settle litigation with originator Merck.
